Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Antioxidant Therapy (Alpha Lipoic Acid, ALA) in OSA Patients

NCT05009901 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05009901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05009901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Antioxidant Therapy (Alpha Lipoic Acid, ALA) in OSA Patients
Lead sponsor
University of British Columbia
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 1, 2022
Completion date
August 31, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea of adult